Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003

Clinical Infectious Diseases

Volumn 42, Issue 12, 2006, Pages 1702-1710

  Munsiff, Sonal S ^a,c   Li, Jiehui ^a   Cook, Sharlette V ^a   Piatek, Amy ^a   Laraque, Fabíenne ^a   Ebrahímzadeh, Adeleh ^b   Fujiwara, Paula I ^a,c  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTENSIVE CARE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT COMPLIANCE; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UNITED STATES;

ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NEW YORK CITY; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 33744811657     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/504325     Document Type: Review

References (21)

1. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328:521-6.
2. Frieden TR, Woodley CL, Crawford JT, Lew D, Dooley SM. The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error. Tuber Lung Dis 1996; 77:407-13.
3. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City: turning the tide. N Engl J Med 1995; 333:229-33.
4. Fujiwara PI, Cook SV, Rutherford CM, et al. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Intern Med 1997; 157:531-6.
5. Tuberculosis in New York City, 2003: information summary. New York: New York City Department of Health and Mental Hygiene, 2004.
6. Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Atlanta: Department of Health and Human Services, 1985.
7. Hawkins JE, Wallace R Jr, Brown BA. Antibacterial susceptibility tests: mycobacteria. In: Balows A, Hausler WJ Jr, Herrmann K, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington, DC: American Society for Microbiology, 1991:1138-52.
8. World Health Organization. Anti-tuberculosis drug resistance in the world. WHO/TB/97.229. Geneva: World Health Organization, 1997.
9. Gasner MR, Maw KL, Feldman GE, Fujiwara PI, Frieden TR. The use of legal action in New York City to ensure treatment of tuberculosis. N Engl J Med 1999; 340:359-66.
10. Frieden TR, Sherman LF, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 1996; 276:1229-35.
11. Driver CR, Balcewicz-Sablinska MK, Kim Z, Scholton J, Munsiff SS. Contact investigations in congregate settings, New York City. Int J Tuberc Lung Dis 2003; 7(Suppl 3):S432-8.
12. Frieden TR, Cairns G, Dorsinville M, Larkin C. Tuberculosis in New York City's homeless. Pharos Alpha Omega Alpha Honor Med Soc 1995; 58:45.
13. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330:1710-6.
14. Dye C, Williams BG, Espinal MA, Raviglione MC. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis. Science 2002; 295:2042-6.
15. Moore M, Onorato ID, McCray E, Castro KG. Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA 1997; 278:833-7.
16. Espinal MA, Laserson K, Camacho M, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001; 5:887-93.
17. Clark CM, Li J, Driver CR, Munsiff SS. Risk factors for drug-resistant tuberculosis among non-US-born persons in New York City. Int J Tuberc Lung Dis 2005; 9:964-9.
18. Jasmer RM, Hahn JA, Small PM, et al. A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med 1999; 130:971-8.
19. Munsiff SS, Bassoff T, Nivin B, et al. Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. Emerg Infect Dis 2002; 8:1230-8.
20. Maloney SA, Pearson ML, Gordon MT, Del Castillo R, Boyle JF, Jarvis WR. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med 1995; 122:90-5.
21. Centers for Disease Control and Prevention (CDC). Reported tuberculosis in the United States, 2003. Atlanta, GA: US Department of Health and Human Services, CDC, 2004.